Parnell Pharmaceuticals Holdings Ltd Stock Nasdaq
Equities
AU0000XINEU9
Pharmaceuticals
Sales 2020 | 30M 19.82M | Sales 2021 | 34.17M 22.58M | Capitalization | 4.08K 2.7K |
---|---|---|---|---|---|
Net income 2020 | -15M -9.91M | Net income 2021 | -1M -661K | EV / Sales 2020 | 2.18 x |
Net Debt 2020 | 56.16M 37.11M | Net Debt 2021 | 58.89M 38.92M | EV / Sales 2021 | 1.72 x |
P/E ratio 2020 |
-0.56
x | P/E ratio 2021 |
-
| Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 10-01-31 |
Joe Rosentel
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Pablo Lamberto
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay B. Benear
BRD | Director/Board Member | - | - |
Doug Schillinger
BRD | Director/Board Member | 50 | - |
Eric Moore
BRD | Director/Board Member | - | 20-12-20 |
1st Jan change | Capi. | |
---|---|---|
-15.35% | 76.23B | |
-9.19% | 6.67B | |
+24.75% | 3.7B | |
-1.11% | 3.21B | |
+6.08% | 1.52B | |
-15.13% | 1.37B | |
-25.63% | 1.24B | |
-7.62% | 1.21B | |
-10.84% | 1.17B |